Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies.

Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies. Am J Med. 2010 Jul; 123(7):S2-S10.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.